NASDAQ$EHTH
eHealth Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Announced fourth quarter and fiscal year 2020 results, demonstrating progress in building capabilities and positioning for future market opportunities.
eHealth, Inc. reported a decrease in revenue for the fourth quarter of 2020, totaling $293.3 million, a 3% decrease compared to the fourth quarter of 2019. GAAP net income for the quarter was $59.9 million, a 33% decrease compared to the same period in the previous year. The company made investments in its e-commerce platform and implemented a program to improve member retention.
- Revenue for the fourth quarter of 2020 was $293.3 million, a 3% decrease compared to $301.7 million for the fourth quarter of 2019.
- GAAP net income for the fourth quarter of 2020 was $59.9 million compared to net income of $88.8 million for the fourth quarter of 2019.
- Adjusted EBITDA was $84.2 million for the fourth quarter of 2020 compared to $142.6 million for the fourth quarter of 2019.
- Fourth quarter 2020 approved members for Medicare Advantage products of 217,278, a 30% increase compared to the fourth quarter of 2019.
Headline financials
Revenue & EPS history
eHealth · Revenue · Quarterly
$293M
Revenue by segment
eHealth · $270M total across 1 segment · Q4 2020
- Medicare$270M-4.5%100.0%
Forward guidance
eHealth is providing its guidance for the full year ending December 31, 2021, excluding the potential impact from the agreement with H.I.G. Capital for a $225 million investment announced on January 29, 2021.
Tailwinds
- Total revenue is expected to be in the range of $660.0 million to $700.0 million.
- Revenue from the Medicare segment is expected to be in the range of $621.0 million to $659.0 million.
- Revenue from the Individual, Family and Small Business segment is expected to be in the range of $39.0 million to $41.0 million.
- GAAP net income is expected to be in the range of $42.0 million to $57.0 million.
- Adjusted EBITDA is expected to be in the range of $100.0 million to $115.0 million.
Headwinds
- Medicare segment profit is expected to be in the range of $138.0 million to $155.0 million.
- Individual, Family and Small Business segment profit is expected to be in the range of $18.0 million to $19.0 million.
- Corporate shared service expenses, excluding stock-based compensation and depreciation and amortization expense, is expected to be in the range of $56.0 million to $59.0 million.
- Cash used in operations is expected to be in the range of $85.0 million to $95.0 million, and cash used for capital expenditures is expected to be in the range of $24.0 million to $27.0 million.
- GAAP net income per diluted share is expected to be in the range of $1.53 to $2.08 per share.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
-1.0%
Avg return
Earnings day
-1.1%
Avg return
5 days after
+0.6%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+25.2%
Q3 2022
Best reaction
-34.3%
Q2 2014
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.5% | -7.1% | -12.7% | |
| Q4 2025 | -30.7% | -17.5% | -32.3% | |
| Q3 2025 | -21.8% | -16.2% | -22.9% | |
| Q1 2025 | +23.2% | +19.2% | -8.1% | |
| Q4 2024 | +3.3% | -5.7% | -28.2% | |
| Q3 2024 | +9.2% | +3.5% | +12.2% | |
| Q2 2024 | -12.8% | -7.7% | -18.8% | |
| Q1 2024 | +12.4% | +8.2% | +9.4% | |
| Q4 2023 | -8.2% | -7.1% | -14.6% | |
| Q3 2023 | -8.5% | -11.7% | +2.1% | |
| Q2 2023 | -0.1% | -1.1% | -14.2% | |
| Q1 2023 | +15.1% | +8.2% | +49.1% | |
| Q4 2022 | -8.4% | +2.5% | +5.4% | |
| Q3 2022 | +25.2% | +27.8% | +47.4% | |
| Q2 2022 | -2.7% | +16.8% | -32.2% | |
| Q1 2022 | +22.5% | +31.1% | +31.1% | |
| Q4 2021 | -16.7% | -25.5% | -20.1% | |
| Q3 2021 | -25.8% | -30.7% | -35.2% | |
| Q2 2021 | -5.9% | -9.3% | -28.6% | |
| Q1 2021 | -0.7% | -5.2% | -8.4% | |
| Q4 2020 | +5.9% | +6.6% | +19.4% | |
| Q3 2020 | -6.8% | -8.2% | -8.7% | |
| Q2 2020 | -31.1% | -36.9% | -40.3% | |
| Q1 2020 | -8.1% | -7.1% | +12.4% | |
| Q4 2019 | -0.6% | -13.7% | -22.3% | |
| Q3 2019 | +0.2% | +10.8% | +39.3% | |
| Q2 2019 | +24.8% | +21.5% | +10.5% | |
| Q1 2019 | +3.7% | -2.0% | +4.3% | |
| Q4 2018 | -3.6% | -7.2% | -4.9% | |
| Q3 2018 | +13.2% | +15.2% | +23.0% | |
| Q2 2018 | -3.6% | -1.2% | +24.6% | |
| Q1 2018 | +17.3% | +21.6% | +31.9% | |
| Q4 2017 | -16.2% | -4.1% | -12.2% | |
| Q3 2017 | +7.0% | +15.3% | +3.5% | |
| Q2 2017 | -5.3% | -8.3% | +23.3% | |
| Q1 2017 | +23.2% | +39.6% | +59.9% | |
| Q4 2016 | +8.9% | +6.3% | +2.5% | |
| Q3 2016 | -31.8% | -30.2% | -5.6% | |
| Q2 2016 | -29.4% | -32.2% | -18.6% | |
| Q1 2016 | +23.2% | — | — | |
| Q4 2015 | +0.7% | — | — | |
| Q3 2015 | -4.2% | — | — | |
| Q2 2015 | +21.4% | — | — | |
| Q1 2015 | +13.5% | — | — | |
| Q4 2014 | -3.6% | — | — | |
| Q3 2014 | +15.4% | — | — | |
| Q2 2014 | -34.3% | — | — | |
| Q1 2014 | -12.3% | — | — | |
| Q4 2013 | -8.5% | — | — | |
| Q3 2013 | +9.6% | — | — | |
| Q2 2013 | -1.8% | — | — | |
| Q1 2013 | +7.3% | — | — | |
| Q4 2012 | -22.8% | — | — | |
| Q3 2012 | +9.5% | — | — | |
| Q4 2011 | -1.1% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -2.5% | — | — | |
| Q3 2010 | -3.1% | — | — | |
| Q3 2011 | -3.1% | — | — | |
| Q4 2010 | -7.0% | — | — | |
| Q2 2011 | -7.0% | — | — | |
| Q2 2010 | -7.0% | — | — | |
| Q1 2010 | +2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro